HealthNewsPoliticsTop StoryUS

Biden admin. moves to protect abortion seekers

The Biden administration is updating the nation’s main health privacy law to offer stronger legal protections to people who obtain abortions in their state or who cross state lines for the procedure, as well as their doctors and loved ones. The Department of Health and Human Services’ Office for Civil Rights on Wednesday will issue a Notice of Proposed Rulemaking to bar health care providers and insurers from turning over information to state officials for the purpose of investigating, suing or prosecuting someone for seeking or providing a legal abortion. The Associated Press has the story:

Biden admin. moves to protect abortion seekers

Newslooks- WASHINGTON (AP)

The White House on Wednesday proposed a new federal rule that aims to limit how law enforcement and state officials collect medical records from health providers and insurers if they pursue criminal or civil investigations into women who flee their home states to seek abortions elsewhere.

The proposal, prompted by a string of blows to abortion access across the country, follows a federal judge’s ruling on Friday that threatens to pull the most commonly used abortion pill, mifepristone, off the market.

The White House’s proposed rule would prohibit health care organizations from sharing personal medical records with authorities for investigations related to reproductive care in states where a woman legally obtained an abortion. While medical records are protected by federal privacy laws, health providers and insurers can be compelled to turn over medical records with a court order.

FILE – Boxes of the drug mifepristone sit on a shelf at the West Alabama Women’s Center in Tuscaloosa, Ala., March 16, 2022. Health and Human Services Secretary Xavier Becerra on Sunday, April 9, 2023, stressed that women for now continue to have access to the abortion medication mifepristone after the Texas judge stayed his ruling for a week so federal authorities could file a challenge. The drug was approved by the FDA in 2000. (AP Photo/Allen G. Breed, File)

Doctors around the country have voiced concerns about protecting that medical information from law enforcement officials, said Melanie Fontes Rainer, the director of the office of civil rights at the U.S. Department of Health and Human Services, which proposed the rule change.

“We’ve had many conversations with providers, major medical associations and patient advocates about what they’re seeing on the ground and how the federal government can be helpful in ensuring medical records are kept private,” she said in a statement.

Since the U.S. Supreme Court overturned the constitutional right to an abortion last year, some women living in a stretch of Southern and Midwestern states that have largely outlawed abortion now travel hours to other states to get abortions legally.

White House officials warned on Wednesday that access to nearly any medication is in jeopardy after a federal judge ordered that a pill commonly used for abortions be pulled off the market, and they said they’re consulting with lawmakers, doctors and pharmacies to fight the ruling.

In this image from video from the Senate Judiciary Committee, Matthew Kacsmaryk listens during his confirmation hearing before the Senate Judiciary Committee on Capitol Hill in Washington, on Dec. 13, 2017. U.S. District Judge Matthew Kacsmaryk is holding a hearing in a case that could throw into jeopardy access to the nation’s most common method of abortion. He is a former attorney for a Christian legal group who critics say is being sought out by conservative litigants because they believe he’ll be sympathetic to their causes. (Senate Judiciary Committee via AP)

Texas Judge Matthew Kacsmaryk’s decision to restrict access to the abortion pill mifepristone threatens to upend abortion access for the entire country by Friday if another court doesn’t step in. The Justice Department appealed the ruling on Monday.

Vice President Kamala Harris will meet Wednesday with President Joe Biden’s Cabinet to discuss other ways the administration can respond to the latest in a string of blows to abortion access in the U.S. Harris planned to discuss the proposed rule at a meeting with President Joe Biden’s Cabinet, which will include Attorney General Merrick Garland and Health and Human Services Secretary Xavier Becerra, according to two senior White House officials who spoke on the condition of anonymity to preview the meeting. The Cabinet will also strategize responses to statewide bans on abortion and Texas Judge Matthew Kacsmaryk’s order to pull the abortion pill mifepristone off the market, which threatens to upend abortion access for the entire country by Friday if another court doesn’t step in. The Justice Department appealed the ruling on Monday.

Vice President Kamala Harris speaks during a ceremonial promotion of Jacob Middleton to Brigadier General in the U.S. Space Force in the Eisenhower Executive Office Building on the White House campus, Tuesday, April 4, 2023, in Washington. (AP Photo/Patrick Semansky)

For months, the White House has struggled to counter the abortion restrictions Republican-led states have rolled out since the U.S. Supreme Court overturned the constitutional right to the medical procedure last June.

Many abortion clinics, some offering medication-only abortions, have relocated to Democratic-leaning states, preserving some sort of access for millions of women around the country. Now, the Biden administration is staring down a challenge to abortion access that could alter how women get abortions nationwide.

Kacsmaryk’s decision would revoke the Food and Drug Administration’s approval of mifepristone, one of two drugs used in what is considered the most effective and safest way to carry out a medication abortion. There is no precedent for a lone judge to overrule the FDA’s medical decisions, and pharmaceutical executives said Monday they fear the ruling could jeopardize the approval of vaccines and other medications.

A competing ruling by a federal judge in Spokane, Washington, issued on the same day directed federal officials not to hinder access to the drug in at least 17 states where Democrats sued to keep the drug’s availability intact. The issue is likely to be decided by the Supreme Court.

FILE – Bottles of the drug misoprostol sit on a table at the West Alabama Women’s Center, March 15, 2022, in Tuscaloosa, Ala. White House officials warned on Wednesday, April 12, 2023, that access to nearly any medication is in jeopardy after a federal judge ordered that mifepristone, a pill commonly used for abortions, be pulled off the market, and they said they’re consulting with lawmakers, doctors and pharmacies to fight the ruling. (AP Photo/Allen G. Breed, File)

Meanwhile, the Biden administration is still trying to stifle strict new laws that more than a dozen states have imposed to outlaw abortions. The White House will roll out a proposed rule that aims to limit the information law enforcement and state officials can collect from health care providers and insurers to pursue criminal, civil or administrative investigations into women who flee their home states to seek abortions elsewhere.

Under the proposed rule, health care organizations would be prohibited from sharing personal medical records with authorities for investigations related to abortions in states where a woman legally obtained the care. As it stands, health providers and insurers can be compelled to turn over medical records with a court order.

Doctors around the country have voiced concerns about protecting that medical information from law enforcement officials, said Melanie Fontes Rainer, the director of the office of civil rights at HHS.

“We’ve had many conversations with providers, major medical associations and patient advocates about what they’re seeing on the ground and how the federal government can be helpful in ensuring medical records are kept private,” she said in a statement.

Read more U.S. news

Previous Article
Wall Street stocks rise on cooler inflation data
Next Article
NPR quits Twitter over ‘State-affiliated’ label

How useful was this article?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this article.

Latest News

Menu